Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis

Acta Dermato-Venereologica

Volumn 85, Issue 3, 2005, Pages 236-239

  Tzung, Tien Yi ^a,b   Wu, Jen Chin ^a   Hsu, Nei Jen ^a   Chen, Ya Hui ^a   Ger, Luo Ping ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Calcipotriol; Psoriasis; Tazarotene

Indexed keywords

CALCIPOTRIOL; PETROLATUM; TAZAROTENE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MALE; OINTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PSORIASIS VULGARIS; SCHOOL CHILD; SINGLE BLIND PROCEDURE; SKIN BURNING SENSATION; SKIN IRRITATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; CHILD; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NICOTINIC ACIDS; OINTMENTS; PETROLATUM; PROSPECTIVE STUDIES; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 18844419204     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.1080/00015550510027405     Document Type: Article

References (17)

1. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51-59.
2. Bowman PH, Maloney JE, Koo J. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. J Am Acad Dermatol 2002; 46: 907-913.
3. Veien NK, Bjerke JR, Rossmann-Ringdahl I, Jakobsen HB. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol 1997; 137: 581-586.
4. Guenther LC, Poulin YP, Pariser DM. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis. Clin Ther 2000; 22: 1225-1238.
5. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol 2000; 143: 1275-1278.
6. Tanghetti EA. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene ± corticosteroid. Cutis 2000; 66 (6 Suppl): 12-18.
7. David C. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment. Cutis 2000; 66 (6 Suppl): 19-24.
8. Witman PM. Topical therapies for localized psoriasis. Mayo Clin Proc 2001; 76: 943-949.
9. Tanghetti EA. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid. Cutis 2000; 66 (6 Suppl): 4-11.
10. Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997; 37: 85-92.
11. Gollnick HP, Finzi AF, Marks R, Barker JN, Jansen C, Revuz J, et al. Optimising the use of tazarotene in clinical practice: consensus statement from the European Advisory Panel for tazarotene (Zorac™). Dermatology 1999; 199: 40-46.
12. Salmhofer W, Maier H, Soyer HP, Honigsmann H, Hodl S. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. Acta Derm Venereol 2000; 211 (Suppl): 5-8.
13. Lebwohl M, Ast E, Callen JP, Cullen SI, Hong SR, Kulp-Shorten CL, et al. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. J Am Acad Dermatol 1998; 38: 705-711.
14. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45: 487-498.
15. Guenther L, Cambazard F, Van de Kerkhof PCM, Snellman E, Kragballe J, Chu AC, et al. Efficacy and safety of a new combination of calcipotriol and beta-methasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002; 147: 316-323.
16. Molin L, Cutler TP, Helander I, Nyfors B, Downes N. Comparative efficacy of calcipotriol (MC 930) cream and betamethasone 17-valerate cream in the treatment of chronic psoriasis. A randomized, double-blind, parallel group multicentre study. Br J Dermatol 1997; 136: 89-93.
17. Kullavanijaya P, Gritiyarangsan P, Huiprasert P, Leenutaphong V. Treatment of psoriasis vulgaris with topical vitamin D analogue (calcipotriol): open multi-center study. J Med Assoc Thai 1999; 82: 874-876.